loadpatents
Patent applications and USPTO patent grants for NEWLANDER; Kenneth Allen.The latest application filed is for "enhancer of zeste homolog 2 inhibitors".
Patent | Date |
---|---|
Enhancer Of Zeste Homolog 2 Inhibitors App 20180162845 - BRACKLEY, III; James A. ;   et al. | 2018-06-14 |
Enhancer Of Zeste Homolog 2 Inhibitors App 20170334891 - KNIGHT; Steven David ;   et al. | 2017-11-23 |
Enhancer of zeste homolog 2 inhibitors Grant 9,790,212 - Blackledge, Jr. , et al. October 17, 2 | 2017-10-17 |
Enhancer Of Zeste Homolog 2 Inhibitors App 20170029412 - BLACKLEDGE, JR.; Charles William ;   et al. | 2017-02-02 |
Enhancer of zeste homolog 2 inhibitors Grant 9,505,745 - Blackledge, Jr. , et al. November 29, 2 | 2016-11-29 |
Indoles Grant 9,402,836 - Brackley, III , et al. August 2, 2 | 2016-08-02 |
Enhancer of Zeste Homolog 2 inhibitors Grant 9,382,234 - Knight , et al. July 5, 2 | 2016-07-05 |
Enhancer Of Zeste Homolog 2 Inhibitors App 20160102083 - BLACKLEDGE, JR.; Charles William ;   et al. | 2016-04-14 |
Indoles App 20150313887 - BRACKLEY, III; James ;   et al. | 2015-11-05 |
Enhancer Of Zeste Homolog 2 Inhibitors App 20150307480 - KNIGHT; Steven David ;   et al. | 2015-10-29 |
Azaindazoles Grant 9,073,924 - Burgess , et al. July 7, 2 | 2015-07-07 |
Enhancer Of Zeste Homolog 2 Inhibitors App 20150126522 - Burgess; Joelle Lorraine ;   et al. | 2015-05-07 |
Azaindazoles App 20140343056 - Burgess; Joelle Lorraine ;   et al. | 2014-11-20 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20140296224 - ADAMS; Nicholas D. ;   et al. | 2014-10-02 |
Indoles Grant 8,765,792 - Knight , et al. July 1, 2 | 2014-07-01 |
Indoles App 20130245016 - Knight; Steven David ;   et al. | 2013-09-19 |
Quinoline derivatives as P13 kinase inhibitors Grant 8,404,837 - Adams , et al. March 26, 2 | 2013-03-26 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20120165321 - Adams; Nicholas D. ;   et al. | 2012-06-28 |
Pyridosulfonamide Derivatives As P13 Kinase Inhibitors App 20100311736 - Adams; Nicholas D. ;   et al. | 2010-12-09 |
Pyridopyrimidine Derivatives As P13 Kinase Inhibitors App 20100204222 - Newlander; Kenneth Allen ;   et al. | 2010-08-12 |
Quinazoline Derivatives As P13 Kinase Inhibitors App 20100179144 - Adams; Nicholas D. ;   et al. | 2010-07-15 |
Azaindole inhibitors of Aurora kinases Grant 7,605,266 - Dhanak , et al. October 20, 2 | 2009-10-20 |
Azaindole inhibitors of aurora kinases Grant 7,495,102 - Sarpong , et al. February 24, 2 | 2009-02-24 |
Quinazoline Derivatives As P13 Kinase Inhibitors App 20090018131 - ADAMS; Nicholas D. ;   et al. | 2009-01-15 |
Azaindole inhibitors of aurora kinases App 20080306120 - Dhanak; Dashyant ;   et al. | 2008-12-11 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20080300239 - Adams; Nicholas D. ;   et al. | 2008-12-04 |
Azaindole inhibitors of aurora kinases Grant 7,419,988 - Dhanak , et al. September 2, 2 | 2008-09-02 |
Compounds, Compositions, and Methods App 20080176830 - Adams; Nicholas D. ;   et al. | 2008-07-24 |
Azaindole Inhibitors Of Aurora Kinases App 20080081808 - Sarpong; Martha A. ;   et al. | 2008-04-03 |
Azaindole Inhibitors Of Aurora Kinases App 20080004308 - Dhanak; Dashyant ;   et al. | 2008-01-03 |
Compounds, compositions and methods App 20070254870 - Bergnes; Gustave ;   et al. | 2007-11-01 |
Azaindole inhibitors of aurora kinases Grant 7,282,588 - Dhanak , et al. October 16, 2 | 2007-10-16 |
Azaindole Inhibitors Of Aurora Kinases App 20070149561 - DHANAK; Dashyant ;   et al. | 2007-06-28 |
Compounds, compositions and methods Grant 7,208,487 - Bergnes , et al. April 24, 2 | 2007-04-24 |
Compounds, compositions and methods App 20060052360 - Bergnes; Gustave ;   et al. | 2006-03-09 |
Compounds Grant 5,908,960 - Newlander June 1, 1 | 1999-06-01 |
Bicyclic fibrinogen antagonists Grant 5,693,636 - Bondinell , et al. December 2, 1 | 1997-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.